US Patent 11992531 C
Patent 11992531 was granted and assigned to C4 Therapeutics on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+29 properties)
Article (+314 characters)
US Patent 11992531 C
Article
Patent abstract
This invention provides Degronimers that have carbon-linked E3 Ubiquitin Ligase targeting moieties (Degrons), which can be linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew J. Phillips0
Christopher G. Nasveschuk0
Gesine Kerstin Veits0
Harit U. Vora0
James A. Henderson0
Kiel Lazarski0
Minsheng He0
Yanke Liang0
Date of Patent
May 28, 2024
0Patent Application Number
171077810
Date Filed
November 30, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11992531 C
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
